These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7981402)
1. Interim analysis for randomized clinical trials: simulating the predictive distribution of the log-rank test statistic. Chang MN; Shuster JJ Biometrics; 1994 Sep; 50(3):827-33. PubMed ID: 7981402 [TBL] [Abstract][Full Text] [Related]
2. A likelihood ratio test for cancer screening trials. Self SG; Etzioni R Biometrics; 1995 Mar; 51(1):44-50. PubMed ID: 7766795 [TBL] [Abstract][Full Text] [Related]
3. Exact permutational tests for group sequential clinical trials. Mehta CR; Patel N; Senchaudhuri P; Tsiatis A Biometrics; 1994 Dec; 50(4):1042-53. PubMed ID: 7786986 [TBL] [Abstract][Full Text] [Related]
4. A generalized log-rank test for interval-censored failure time data via multiple imputation. Huang J; Lee C; Yu Q Stat Med; 2008 Jul; 27(17):3217-26. PubMed ID: 18254128 [TBL] [Abstract][Full Text] [Related]
5. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment. Whitehead J; Matsushita T Stat Med; 2003 Mar; 22(5):677-87. PubMed ID: 12587099 [TBL] [Abstract][Full Text] [Related]
6. Design considerations in crossover trials with a single interim analysis and serial patient entry. Cook RJ; Willan AR Biometrics; 1996 Jun; 52(2):732-9. PubMed ID: 8672709 [TBL] [Abstract][Full Text] [Related]
7. Sample size calculation for the weighted rank statistics with paired survival data. Jung SH Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148 [TBL] [Abstract][Full Text] [Related]
8. Dynamic comparison of Kaplan-Meier proportions: monitoring a randomized clinical trial with a long-term binary endpoint. Brittain E; Follmann D; Yang S Biometrics; 2008 Mar; 64(1):189-97. PubMed ID: 17680830 [TBL] [Abstract][Full Text] [Related]
9. Assessment of futility in clinical trials. Snapinn S; Chen MG; Jiang Q; Koutsoukos T Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426 [TBL] [Abstract][Full Text] [Related]
10. A two-stage procedure for survival studies with surrogate endpoints. Flandre P; O'Quigley J Biometrics; 1995 Sep; 51(3):969-76. PubMed ID: 7548712 [TBL] [Abstract][Full Text] [Related]
11. Bayesian variable selection method for censored survival data. Faraggi D; Simon R Biometrics; 1998 Dec; 54(4):1475-85. PubMed ID: 9883546 [TBL] [Abstract][Full Text] [Related]
16. Efficient estimation for patient-specific rates of disease progression using nonnormal linear mixed models. Zhang P; Song PX; Qu A; Greene T Biometrics; 2008 Mar; 64(1):29-38. PubMed ID: 17501938 [TBL] [Abstract][Full Text] [Related]
17. A log-rank test for equivalence of two survivor functions. Wellek S Biometrics; 1993 Sep; 49(3):877-81. PubMed ID: 8241376 [TBL] [Abstract][Full Text] [Related]
18. A robust approach to t linear mixed models applied to multiple sclerosis data. Lin TI; Lee JC Stat Med; 2006 Apr; 25(8):1397-412. PubMed ID: 16220509 [TBL] [Abstract][Full Text] [Related]
19. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing. Tan M; Xiong X; Kutner MH Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648 [TBL] [Abstract][Full Text] [Related]